The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Fisher Asset Management LLC

Fisher Asset Management LLC lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 100.7% in the 4th quarter, Holdings Channel reports. The firm owned 120,868 shares of the medical device company’s stock after purchasing an additional 60,637 shares during the quarter. Fisher Asset Management LLC’s holdings in Cooper Companies were worth $11,111,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in COO. Ashton Thomas Securities LLC acquired a new position in Cooper Companies during the third quarter worth about $25,000. Byrne Asset Management LLC acquired a new position in Cooper Companies during the fourth quarter worth about $33,000. Covestor Ltd raised its position in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after acquiring an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. raised its position in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after acquiring an additional 275 shares during the last quarter. Finally, West Financial Advisors LLC acquired a new position in Cooper Companies during the fourth quarter worth about $49,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

Cooper Companies stock opened at $91.65 on Tuesday. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The firm has a 50 day moving average price of $92.63 and a 200 day moving average price of $99.59. The company has a market cap of $18.29 billion, a price-to-earnings ratio of 47.00, a PEG ratio of 2.25 and a beta of 1.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the previous year, the firm earned $0.87 earnings per share. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of research reports. Citigroup cut their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Morgan Stanley lowered their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Wells Fargo & Company lifted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Finally, StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.22.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.